MalaysiaMalaysia is Southeast Asia's most sophisticated life-sciences hub, offering a streamlined MDA regulatory framework, a rapidly expanding middle class, and gateway access to ASEAN markets. Taevas combines deep local regulatory expertise with end-to-end comm
Select an industry to see regulatory pathways, services, and how Taevas supports your Malaysia market entry.
Medical Device Authority (MDA), Ministry of Health Malaysia
Malaysia's medical device sector is regulated under the Medical Device Act 2012 and overseen by the Medical Device Authority (MDA), which classifies devices into four risk classes (A through D). The market is valued at over USD 1.5 billion and is a recognised ASEAN manufacturing hub attracting multinational investment. Taevas provides end-to-end support from device classification and MDDB registration through to post-market surveillance and commercial launch.
All medical devices sold in Malaysia must be classified under MDA's four-tier risk framework (Class A to D) before registration can proceed. Taevas conducts classification assessments and prepares supporting technical documentation aligned with MDA guidelines.
Products must be listed on the Malaysian Device Data Bank (MDDB) via the MeDC@St online portal before they can be legally marketed. Taevas manages the full submission including technical files, conformity assessment, and liaison with MDA reviewers.
Importers and distributors of medical devices in Malaysia must hold a valid Establishment Licence issued by the MDA. Taevas assists foreign manufacturers in appointing a licensed local Authorised Representative and securing the required import licences.
Registered device holders must maintain ongoing vigilance reporting, periodic safety update reports, and field safety corrective actions in compliance with MDA requirements. Taevas manages all post-market obligations to keep your registration in good standing.
Taevas has built a proven track record helping international life-sciences companies navigate Malaysia's regulatory environment and establish profitable commercial operations, combining on-the-ground expertise with a full-service market entry infrastructure.
Our in-country regulatory specialists have deep working knowledge of MDA, NPRA, and FSQD processes, ensuring submissions are accurate, complete, and positioned for the fastest possible approval timelines in Malaysia.
Malaysia's regulatory framework is harmonised with ASEAN guidelines, meaning a successful Malaysia entry often accelerates approvals across Thailand, Indonesia, Vietnam, and the broader Southeast Asian region.
Taevas's pre-built regulatory templates, established relationships with Malaysian authorities, and parallel-track submission strategies consistently reduce time to first sale for our clients in Malaysia.
We maintain active relationships with qualified medical device, pharmaceutical, and consumer health distributors across Peninsular and East Malaysia, enabling rapid commercial activation without the delays of building a network from scratch.
Taevas has cultivated relationships with leading Malaysian clinicians, pharmacists, and healthcare associations, providing our clients with credible clinical endorsement and professional community engagement from day one.
From initial regulatory strategy through product registration, import logistics, warehousing, distribution, and marketing, Taevas delivers a single accountable partner for every stage of your Malaysia market journey.
Speak with a Taevas Malaysia specialist today to receive a tailored market entry assessment and regulatory roadmap for your product category.